- Tony Gibney, Managing Director, Leerink Swann LLC
Leerink Swann LLC
Tony Gibney is a Managing Director at Leerink Swann LLC in New York, where he is a senior leader of the Firm's biopharmaceutical investment banking franchise.
has primary coverage responsibilities for selected East Coast biopharmaceutical and European pharmaceutical clients.
Tony joined Leerink in mid-2009 along with 18 other investment bankers from Merrill Lynch.
At Merrill, Tony led the East Coast biotechnology and branded specialty pharmaceutical banking effort for the majority of his 10-year tenure.
Prior to Merrill, Tony was an analyst and associate in the Healthcare Investment Banking Group at Lehman Brothers from 1993 to 1999.
has executed over 100 M&A transactions, book-run financings and other structured transactions over his
20-year life sciences investment banking career.
Successfully concluded transactions have included private placements, initial public offerings, add-on offerings, convertible offerings and royalty-based financing transactions, as well as sell-side, buy-side and structured collaboration strategic advisory assignments for life science clients.
At Leerink, Tony has helped to combine the Firm's MedaCorp, Consulting and other unique knowledge resources with senior banking execution experience to better establish the Firm's leadership roles in financings and M&A assignments for larger, more visible biopharmaceutical clients.
In such transactions, the Firm often collaborates with bulge bracket peers, whose resources generally complement Leerink's capabilities, to improve transactional success.
has executed transactions for over 30 biopharmaceutical companies while at Leerink
, including multiple deals for several clients.